Utility of Mobile phone app-assisted screening for heart failure in primary care: Insights from the ECHOS3 registry
Authors:
Open Access
- 22 July 2025
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 439, 133651
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 22 references indexed in Scilit:
- Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionNew England Journal of Medicine, 2024
- Long COVID: a clinical updateThe Lancet, 2024
- An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA scoreNature Medicine, 2024
- Practical Algorithms for Early Diagnosis of Heart Failure and Heart Stress Using NT-proBNP: A Clinical Consensus Statement from the Heart Failure Association of the ESCEuropean Journal of Heart Failure, 2023
- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and ObesityNew England Journal of Medicine, 2023
- Heart Failure Diagnosis in the General Community – Who, how and When? A Clinical Consensus Statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)European Journal of Heart Failure, 2023
- It Is Time to Screen for Heart FailureJACC: Heart Failure, 2022
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart FailureJACC, 2022
- NT-ProBNP and High-Sensitivity Troponin T as Screening Tests for Subclinical Chronic Heart Failure in a General PopulationESC Heart Failure, 2022
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015